Stewart LV - Search Results

1

The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes.

Koethe JR, Eeds A, Stewart LV, Haas DW, Hildreth JEK, Mallal S, Wanjalla C, Perkins J, Ahonkhai A, Dong X, Berhanu R, Dash C. Koethe JR, et al. Among authors: stewart lv. J Acquir Immune Defic Syndr. 2023 Oct 1;94(2S):S42-S46. doi: 10.1097/QAI.0000000000003261. J Acquir Immune Defic Syndr. 2023. PMID: 37707847 Free PMC article.

2

Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.

Brown LK, Kanagasabai T, Li G, Celada SI, Rumph JT, Adunyah SE, Stewart LV, Chen Z. Brown LK, et al. Among authors: stewart lv. Prostate. 2024 Jun;84(9):877-887. doi: 10.1002/pros.24706. Epub 2024 Apr 11. Prostate. 2024. PMID: 38605532

3

The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence.

Smith T, White T, Chen Z, Stewart LV. Smith T, et al. Among authors: stewart lv. Exp Cell Res. 2024 Apr 1;437(1):113991. doi: 10.1016/j.yexcr.2024.113991. Epub 2024 Mar 8. Exp Cell Res. 2024. PMID: 38462208 Free article.

4

Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists.

Williams SD, Smith TM, Stewart LV, Sakwe AM. Williams SD, et al. Among authors: stewart lv. Cells. 2022 Sep 27;11(19):3007. doi: 10.3390/cells11193007. Cells. 2022. PMID: 36230969 Free PMC article.

5

Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.

Olokpa E, Moss PE, Stewart LV. Olokpa E, et al. Among authors: stewart lv. PPAR Res. 2017;2017:9456020. doi: 10.1155/2017/9456020. Epub 2017 Oct 18. PPAR Res. 2017. PMID: 29181019 Free PMC article. Review.

6

The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.

Olokpa E, Bolden A, Stewart LV. Olokpa E, et al. Among authors: stewart lv. J Cell Physiol. 2016 Dec;231(12):2664-72. doi: 10.1002/jcp.25368. Epub 2016 Mar 14. J Cell Physiol. 2016. PMID: 26945682 Free PMC article.

7

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.

Bolden A, Bernard L, Jones D, Akinyeke T, Stewart LV. Bolden A, et al. Among authors: stewart lv. PPAR Res. 2012;2012:929052. doi: 10.1155/2012/929052. Epub 2012 Feb 20. PPAR Res. 2012. PMID: 22448169 Free PMC article.

8

Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.

Akinyeke TO, Stewart LV. Akinyeke TO, et al. Among authors: stewart lv. Cancer Biol Ther. 2011 Jun 15;11(12):1046-58. doi: 10.4161/cbt.11.12.15709. Epub 2011 Jun 15. Cancer Biol Ther. 2011. PMID: 21525782 Free PMC article.

9

The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.

Moss PE, Lyles BE, Stewart LV. Moss PE, et al. Among authors: stewart lv. Exp Cell Res. 2010 Dec 10;316(20):3478-88. doi: 10.1016/j.yexcr.2010.09.015. Epub 2010 Oct 13. Exp Cell Res. 2010. PMID: 20932825 Free PMC article.

10

Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.

Lyles BE, Akinyeke TO, Moss PE, Stewart LV. Lyles BE, et al. Among authors: stewart lv. Cell Cycle. 2009 Jan 15;8(2):268-77. doi: 10.4161/cc.8.2.7584. Cell Cycle. 2009. PMID: 19164938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters